Term
|
Definition
-calcium channel blocker
-promotes smooth muscle relaxation, vasodilation, and enhances oxygenation and perfusion.
-used for SAH
-given q4h
-AKA: Nimodipine |
|
|
Term
|
Definition
| -used to control b/p in a SAH patient |
|
|
Term
|
Definition
|
|
Term
|
Definition
| used to control b/p in a SAH patient |
|
|
Term
|
Definition
|
|
Term
|
Definition
| SAH patient, if other meds dont work |
|
|
Term
|
Definition
-start at 5mg/hr
-15-20mg/hr max
-titrate to MAP |
|
|
Term
|
Definition
-used with SAH patient if MAP is <80-90
-potent vasoconstrictor
-cousin to levophed, but more gentle
-more effective when CO2 is also a problem |
|
|
Term
|
Definition
-antiseizure med to prevent seizures in TBI patients (only is seizures are present)
-effective, but expensive
-no SE
-preferred over dilantin if possible |
|
|
Term
|
Definition
-antiseizure med used with TBI patients when seizures are present
-cheaper than keppra |
|
|
Term
|
Definition
Side Effects: thrush
Concerns: cannot mix w/ tube feedings, easily toxic |
|
|
Term
| Magnesium: Use, Normal & Needed Level |
|
Definition
-SAH patients have a megnesium protocol to decrease vasospasms.
-needs to be >2.5 (normal is 1.8-2.2)
-can be given via gtt or IVPB |
|
|
Term
|
Definition
-vasodilator used to test vasospasms
-injected via artery direct into cerebral vessel via angiography approach |
|
|
Term
|
Definition
-vasodilator used to trest vasospasms
-injected via artery direct into cerebral vessel via angiography approach |
|
|
Term
| Mannitol: Classification, Use |
|
Definition
-osmotic diuretic
-used to decrease intracranial pressure
(serum osmolality levels should be assessed prior to admnistration, should be <320) |
|
|
Term
|
Definition
|
|
Term
| Drugs used to induce coma (7) |
|
Definition
1 Diprivan
2 Pentabarbital
3 Fentanyl
4 Ativan
5 Pancuronium OR
6 Vecronium OR
7 Nimbex |
|
|
Term
| Diabetes Insipidous: Treatment (2) |
|
Definition
-Hypotonic solution (0.45% sodium chloride)
-ml/ml replacement
-Vasopressin gtt (ADH) |
|
|
Term
| Desmopressin- Use, Route, AKA |
|
Definition
-used to remove tumor in DI patients
-IV, nasal, oral
- AKA: DDAVP |
|
|
Term
| SIADH Treatment (2 r/t fluid) |
|
Definition
-fluid restriction <500-800ml/24h
-hypertonic saline (3% sodium solution, recommended for Na <110) |
|
|
Term
|
Definition
-used to treat SIADH
-20-40mg q6-8h
-used with isotonic or hypertonic salutions |
|
|
Term
|
Definition
-Treatment for SIADH
-* Induces ID
-For chronic conditions and if patient is noncompliant with water restriction. |
|
|
Term
|
Definition
|
|
